Deutsche Bank Ag\ Centogene N.V. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$9.02 - $12.93 $76,363 - $109,465	-8,466 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$10.56 - $13.94 $13,791 - $18,205	1,306 Added 18.24%	8,466 $102,000
Q4 2020 Feb 16, 2021	BUY	$9.44 - $13.3 $27,338 - $38,516	2,896 Added 67.92%	7,160 $76,000
Q3 2020 Nov 12, 2020	BUY	$9.3 - $25.16 $22,171 - $59,981	2,384 Added 126.81%	4,264 $40,000
Q2 2020 Aug 13, 2020	BUY	$15.99 - $22.88 $20,595 - $29,469	1,288 Added 217.57%	1,880 $43,000

Q1 2020 May 14, 2020	SELL	$9.76 - $23.8 $351 - $856	-36 Reduced 5.73%	592 $12,000
Q4 2019 Feb 14, 2020	BUY	$8.1 - $14.6 $5,086 - $9,168	628 New	628 $6,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.